Dosage forms comprising AG013736

Details for Australian Patent Application No. 2004226586 (hide)

Owner Pfizer Inc.

Inventors Freddo, James Lawrence; Hu-Lowe, Dana; Steinfeldt, Heidi Marie; Pithavala, Yazdi Kersi

Agent Shelston IP

Pub. Number AU-B-2004226586

PCT Pub. Number WO2004/087152

Priority 60/491,771 31.07.03 US; 60/460,695 03.04.03 US

Filing date 17 March 2004

Wipo publication date 14 October 2004

Acceptance publication date 11 December 2008

International Classifications

A61K 31/4439 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

22 September 2005 PCT application entered the National Phase

  PCT publication WO2004/087152 Priority application(s): WO2004/087152

11 December 2008 Application Accepted

  Published as AU-B-2004226586

9 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004226590-Process for burning sulfur-containing fuels

2004226578-Tissue-adhesive formulations